DKSH has entered an exclusive distribution agreement with ddchem, the leading, Italy-based producer of hardeners for epoxy systems and hot melt polyamides. DKSH will provide ddchem’s products in Spain, Portugal and APAC.
DKSH and Ubiquitome have signed an exclusive agreement in South East Asia, Australia and New Zealand to introduce Liberty16, a handheld, battery-powered, real-time polymerase chain reaction (PCR) device that can fast test and relay sample data via an iPhone app within 40 minutes.
DKSH is 1 of the largest healthcare/pharmaceutical products distributors worldwide, covering over 60 countries, including msia. Because of local law, malaysia is the only country it is listed outside Switzerland where its parent company is listed. We are lucky to have the opportunity to participate in this world class company. It represents well known international pharmaceutical companies like Norvatis, Sanofi, AstraZeneca, abbot and many more. And all these companies are involved in developing covid 19 vaccine. I hope DKSH will be benefited if the vaccine is available in d future
Bclim_83 is absolutely right. This is a direct proxy to their Swiss listed co. 4 us, holding co like tis, we hv no nd to worry. Just hold collect dividend
in term of price there is no surprise,but we talk about revenue,there still a room to grow espeacially when vaccine of Covid 19 start produce,because this company is the only distributor for few vaccine provide by europe & US company.
I thou. the co. have made decision to suspend the dividend for this year, as they are try to conserve cash on reducing high debt, especially the new term loan (500 million) taken on the acquisition of Auric Pacific's distribution business in Mar 19.
Good company and the only DKSH listed outside of switzerland where its parent company listed. It distribute various famous brands in consumer and pharmaceutical companies which their products are essential to daily life. Hopefully, it can distribute covid vaccine from all these MNC once it is available.
Not only pfizer products, it also distribute Astrazeneca products who is also actively involved in vaccine R&D. 1 week ago, it was appointed by Heinz as the sole distributor of its products in Msia
i guess KYY already reserve the bullet to buy in when price drop below RM2.80.See the game just start because KYY know game for Glove will be end 1 day,that why he sold supermx & comfort 3 day ago
Performance Auric also 100% grow within 1year 2 month.Turnover grow from RM332mil to almost RM795mil (Swiss Frans 185mil)show in 1half 2020 report.Just ask yourself ,can you find other company can grow 100% within the year acquisition? with PE 9.82
A vaccine in development by the British-Swedish company AstraZeneca and the University of Oxford is based on a chimpanzee adenovirus called ChAdOx1. Their Phase I/II trial, reported on July 20 in the journal Lancet, found that the vaccine was safe, causing no severe side effects. It raised antibodies against the coronavirus as well as other immune defenses. The vaccine is now in a Phase II/III trial in England, as well as Phase III trials in Brazil and South Africa. The project may deliver emergency vaccines by October. AstraZeneca has said their total manufacturing capacity for the vaccine, if approved, stands at two billion doses.
where is the interesting news? Sinoboy!Margin for distributor very low,it wont contribute high % to our DKSH profit. Dont buy in if u aim for this target.
The German company BioNTech has entered into collaborations with Pfizer, based in New York, and the Chinese drug maker Fosun Pharma to develop their mRNA vaccine. In July, they posted preliminary results from their Phase I/II trials in the United States and Germany. They found that the volunteers produced antibodies against SARS-CoV-2, as well as immune cells called T cells that respond to the virus. Some volunteers experienced moderate side effects such as sleep disturbances and sore arms.
The company expects to start Phase III trials by the end of July. On July 22, the Trump administration awarded a $1.9 billion contract for 100 million doses to be delivered by December and the option to acquire 500 million more doses. If approved, Pfizer said they expect to manufacture over 1.3 billion doses of their vaccine by the end of 2021.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Gemstar
431 posts
Posted by Gemstar > 2020-05-08 10:28 | Report Abuse
Dksh nice play... hopefully rm3 not far away...